British pharmacopoeia 2026

The British Pharmacopoeia 2026 (BP 2026) is the UK’s legally enforceable compendium of pharmaceutical standards, essential for ensuring compliance in medicine development, manufacture, and testing. Effective from 1 January 2026, BP 2026 replaces BP 2025.

Guardat en:
Dades bibliogràfiques
Autor principal: British Pharmacopoeia Commission
Format: Llibre
Idioma:anglès
Publicat: London British Pharmacopoeia Commission 2025
Edició:2026
Matèries:
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

MARC

LEADER 00000nam a22000007a 4500
008 251205b |||||||| |||| 00| 0 eng d
020 |a 9780113231041 
082 |a 615.110941   |b BRI 
100 |a British Pharmacopoeia Commission  |9 10356 
245 |a British pharmacopoeia 2026 
250 |a 2026 
260 |a London  |b British Pharmacopoeia Commission  |c 2025 
300 |a III-1664 
490 |v VOLUME-III 
520 |a The British Pharmacopoeia 2026 (BP 2026) is the UK’s legally enforceable compendium of pharmaceutical standards, essential for ensuring compliance in medicine development, manufacture, and testing. Effective from 1 January 2026, BP 2026 replaces BP 2025. 
650 |a  Great Britain Drugs Standards  |a The British Pharmacopoeia 2026   |9 11899 
952 |0 0  |1 0  |2 ddc  |4 0  |6 615_110941000000000_BRI  |7 0  |9 20211  |a 50008178  |b 50008178  |d 2025-12-05  |e Mehul Traders  |g 22312.50  |l 0  |o 615.110941 BRI  |p JP002311  |r 2025-12-05 16:03:27  |v 25500.00  |w 2025-12-05  |y RB 
999 |c 9913  |d 9913